Overall volumes in futures & options currently stand at 1.68 crore contracts with a turnover of Rs. 17,06,179.09 crore.

Vakrangee Limited has collaborated with Reliance Nippon Life Asset Management Limited (formerly known Capital Asset Management Limited) to distribute mutual funds.

The company's board accepted the binding investment proposal at the highest bid price of Rs. 170 per share, which is close to the stock's 52-week high and a 20 per cent premium to its current price.

The level of 11,078 will be important to watch as the index may face resistance around this level, followed by 11,100. Stocks in news: HCL Tech, Tata Communications, Hindustan Oil Exploration, Vakrangee, Allahabad Bank and SBI. 

Indian markets are likely to continue with their upmove on Friday as global cues are positive. The two key data announced yesterday post the market hours left a lot be desired. The IIP for the month of May came in sharply lower at 3.2%, which is the slowest in the last seven months, while retail inflation jumped to 5%, which could once again make a case for further rate hikes by the RBI. Infosys will be in focus as it is due to announce its quarterly earnings today.  

The stocks that are likely to witness significant movement on the bourses on Friday are Karnataka Bank, Essar Ports, Vikrangee, Ashok Leyland and Goodluck India.

Dr. Reddy's Laboratories has launched Hydroxychloroquine Sulfate Tablets USP, 200 mg, a generic version of Plaquenil Tablets, in the US market. The drug was earlier approved by the US Food and Drug Administration (USFDA).

Diversified company L&T's construction arm has received two Water & Effluent Treatment orders from Madhya Pradesh corporation and Tirunelveli Municipal Corporation.

Equity bellwether indices touched their lifetime highs, but the broader markets refused to join the party and are yet to recover.

Alembic Pharmaceuticals has informed that the company has received tentative approval for its abbreviated new drug Ticagrelor Tablets, 90 mg.